ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Cara Therapeutics Inc

Cara Therapeutics Inc (CARA)

0,4636
0,0062
(1,36%)
Geschlossen 25 Dezember 10:00PM
0,445
-0,0186
(-4,01%)
Nach Börsenschluss: 10:46PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,4636
Gebot
0,44
Fragen
0,443
Volumen
1.208.384
0,4105 Tagesbereich 0,4727
0,2257 52-Wochen-Bereich 1,15
Marktkapitalisierung
Handelsende
0,4574
Handelsbeginn
0,4574
Letzter Handelszeitpunkt
Finanzvolumen
US$ 534.845
VWAP
0,442612
Durchschnittliches Volumen (3 Mio.)
1.484.274
Ausgegebene Aktien
54.855.514
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,21
Gewinn pro Aktie (EPS)
-2,16
Erlöse
20,97M
Nettogewinn
-118,51M

Über Cara Therapeutics Inc

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Cara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CARA. The last closing price for Cara Therapeutics was US$0,46. Over the last year, Cara Therapeutics shares have traded in a share price range of US$ 0,2257 to US$ 1,15.

Cara Therapeutics currently has 54.855.514 shares in issue. The market capitalisation of Cara Therapeutics is US$25,09 million. Cara Therapeutics has a price to earnings ratio (PE ratio) of -0.21.

CARA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.20982.08955223880.25460.51950.2257116429530.35115053CS
40.15952.19960604070.30460.51950.225734387160.34295087CS
120.152749.11547121260.31090.51950.225714842740.33272623CS
260.183665.57142857140.280.51950.225710136280.33230473CS
52-0.1901-29.08061802050.65371.150.22578428340.46399544CS
156-12.2164-96.343848580412.6813.9650.22577185553.93012635CS
260-16.5564-97.276145710917.0229.64730.22577249288.97796092CS

CARA - Frequently Asked Questions (FAQ)

What is the current Cara Therapeutics share price?
The current share price of Cara Therapeutics is US$ 0,4636
How many Cara Therapeutics shares are in issue?
Cara Therapeutics has 54.855.514 shares in issue
What is the market cap of Cara Therapeutics?
The market capitalisation of Cara Therapeutics is USD 25,09M
What is the 1 year trading range for Cara Therapeutics share price?
Cara Therapeutics has traded in the range of US$ 0,2257 to US$ 1,15 during the past year
What is the PE ratio of Cara Therapeutics?
The price to earnings ratio of Cara Therapeutics is -0,21
What is the cash to sales ratio of Cara Therapeutics?
The cash to sales ratio of Cara Therapeutics is 1,2
What is the reporting currency for Cara Therapeutics?
Cara Therapeutics reports financial results in USD
What is the latest annual turnover for Cara Therapeutics?
The latest annual turnover of Cara Therapeutics is USD 20,97M
What is the latest annual profit for Cara Therapeutics?
The latest annual profit of Cara Therapeutics is USD -118,51M
What is the registered address of Cara Therapeutics?
The registered address for Cara Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Cara Therapeutics website address?
The website address for Cara Therapeutics is www.caratherapeutics.com
Which industry sector does Cara Therapeutics operate in?
Cara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7,10
(310,40%)
58,74M
HOURHour Loop Inc
US$ 4,40
(207,69%)
97,42M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
CREVCarbon Revolution Public Ltd
US$ 9,16
(135,48%)
26,95M
AVGRAvinger Inc
US$ 1,45
(125,72%)
107,53M
SLGLSol Gel Technologies Ltd
US$ 0,9798
(-40,62%)
3,07M
DRCTDirect Digital Holdings Inc
US$ 3,71
(-32,55%)
23,82M
CHEKCheck Cap Ltd
US$ 1,55
(-31,11%)
3,49M
SYTASiyata Mobile Inc
US$ 0,5178
(-30,83%)
2,63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15,47
(-30,38%)
147,98k
SVMHSRIVARU Holding Ltd
US$ 0,0338
(20,71%)
280,27M
GTIGraphjet Technology
US$ 0,61
(168,72%)
265,48M
LITMSnow Lake Resources Ltd
US$ 0,5849
(52,84%)
181,22M
LCIDLucid Group Inc
US$ 3,20
(3,23%)
108,75M
RGTIRigetti Computing Inc
US$ 11,35
(3,56%)
108,38M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock